SCHEMBL573723

SCHEMBL573723

Nc1ccno1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14125002 0.67 NOTUM (0.56)
SCHEMBL11149894 0.65
SCHEMBL12427497 0.65
SCHEMBL1351742 0.64 NOTUM (0.63)
SCHEMBL4163797 0.63
SCHEMBL11735548 0.62
SCHEMBL7238701 0.62
SCHEMBL2009212 0.62
SCHEMBL7239683 0.62
SCHEMBL11149882 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4071147-B1 NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF LG CHEMICAL LTD (KR) 2025-03-26 EP claimed
CN-115594691-B Synthetic method of isoxazolo [4,5-b ] pyridine-6-ketone compound 五邑大学 2024-03-26 CN claimed
CN-117700407-A 3, 3-disubstituted indol-2-one compound and preparation method and application thereof 五邑大学 2024-03-15 CN claimed
CN-117630218-A High performance liquid chromatography detection method for sodium sulfaisoxazole intermediate and isomer thereof 江苏天和制药有限公司 2024-03-01 CN claimed
EP-3801529-B1 HIGHLY POTENT TACC3 INHIBITOR AS A NOVEL ANTICANCER DRUG CANDIDATE ONCOCUBE THERAPEUTICS LLC (US) 2023-10-11 EP claimed
CN-115594691-A Synthesis method of isoxazolo [4,5-b ] pyridine-6-ketone compound 五邑大学(CN) 2023-01-13 CN claimed
CN-115279754-A Isoxazole derivatives targeting TACC3 as anticancer agents A2A制药有限公司 2022-11-01 CN claimed
EP-4058447-A1 ISOXAZOLE DERIVATIVES TARGETING TACC3 AS ANTICANCER AGENTS A2A Pharmaceuticals, Inc. (US) 2022-09-21 EP claimed
CN-113416171-A 4, 5-dihydronaphthoisoxazole derivatives and application thereof in antitumor drugs 守恒(厦门)医疗科技有限公司 2021-09-21 CN claimed
CN-113321645-A 5-aminoisoxazole derivative and application thereof in preparation of multi-kinase inhibitor 苏州安睿药业有限公司 2021-08-31 CN claimed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US claimed
US-5830867-A Hemoregulatory peptides for stimulating the myelopoietic system SMITHKLINE BEECHAM CORPORATION (US) 1998-11-03 US claimed
EP-0701446-A4 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1997-04-23 EP claimed
EP-0701446-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1996-03-20 EP claimed
WO-1994027627-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-12-08 WO claimed
EP-0248399-A1 Aminoazole derivatives and their production and use SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1987-12-09 EP claimed
EP-0090275-B1 ISOXAZOLE (5,4-B) PYRIDINES GRUPPO LEPETIT S.p.A. (IT) 1987-10-28 EP claimed
EP-0043024-B1 PROCESS FOR THE PREPARATION OF 5-AMINO ISOXAZOLES HÜLS TROISDORF AKTIENGESELLSCHAFT (DE) 1984-03-28 EP claimed
EP-0043024-A1 Process for the preparation of 5-amino isoxazoles HÜLS TROISDORF AKTIENGESELLSCHAFT (DE) 1982-01-06 EP claimed
EP-0002881-A1 5-Isoxazolylurea derivatives, their preparation, their use and compositions containing them FISONS plc (GB) 1979-07-11 EP claimed